September 28, 2021
Andrea Ochoa, Premier Research’s Vice President, Global Study Start-Up, will lead a conversation on the future of decentralized clinical trials in a special presentation and panel discussion at PPCD 2021.
As a result of the pandemic, we are facing a “new normal” in clinical trial conduct. PPCD 2021 focuses on how this influences the patient’s journey, their involvement as clinical research partners, and strategies for next steps.
Decentralized Clinical Trials — Setting the Scene
September 28, 11-11:15 a.m. CEST
Presenter: Andrea Ochoa
While decentralized clinical trials are not something new, they are now the key topic for the clinical trial industry. With the extraordinary need for a different approach to face-to-face interactions and to decrease demand on hospitals during the pandemic, the “future” for clinical trials has suddenly become the priority.
What does the term “decentralized clinical trials” actually mean? Can we implement all that we envision? How ready are the different stakeholders to embrace such decentralization?
Andrea Ochoa, Premier’s Vice President, Global Study Start-Up, will discuss answers to those questions and more in this presentation.
PANEL DISCUSSION | Decentralized Clinical Trials
September 28, 11:15 a.m.-12 p.m. CEST
Moderator: Andrea Ochoa